1st Quarter - Report · 2026

Filing UUID: f559fcca-9332-4d22-8766-3773cd246f5f
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-20 22:12:40
Income (reported): $10,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

RK STRATEGIES, INC.

Contact: RYAN KANE
Phone: +1 336-383-6805
Address: zip:23518, city:Norfolk, state:VA, street:9650 Nansemond Bay St

Client

ADIAL PHARMACEUTICALS, INC.

Pharmaceutical company

State: VA
Country: US
Effective date: 2024-12-20

Issues lobbied + lobbyists

`HCR` — Health Issues

FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act National Defense Authorization Act, FY27

Lobbyists:

RYAN KANE

Government entities lobbied: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

`DEF` — Defense

FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act National Defense Authorization Act, FY27

Lobbyists:

RYAN KANE

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.